Omnicare Announces Pricing and Increased Size of Offering of 7.75% Senior Subordinated Notes Due 2020
(Thomson Reuters ONE) -
COVINGTON, Ky., September 15, 2011 -- Omnicare, Inc. (NYSE: OCR) (the "Company")
today announced that it has priced its public offering of an additional $150
million aggregate principal amount of its 7.75% Senior Subordinated Notes due
2020. This represents a $50 million increase in the previously announced size of
the offering. The Senior Subordinated Notes were offered at a public offering
price of 100.25%, plus accrued interest from June 1, 2011. The Company expects
to close the transaction on September 20, 2011, subject to customary closing
conditions.
The Company expects to use the net proceeds from the offering of the Senior
Subordinated Notes to redeem the remaining outstanding portion of its 6.875%
Senior Subordinated Notes due 2015 and the remaining outstanding portion of its
6.125% Senior Notes due 2013, and to use any remaining proceeds for general
corporate purposes.
J.P. Morgan, BofA Merrill Lynch, Barclays Capital, Goldman Sachs & Co. and
SunTrust Robinson Humphrey are acting as Joint Book-Running Managers for the
senior subordinated notes offering. Copies of the preliminary prospectus
supplement and related shelf registration statement may be obtained from J.P.
Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
New York, 11717 (tel: 1-866-803-9204), from BofA Merrill Lynch, tel:
1-800-294-1322 or email: dg.prospectus_requests(at)baml.com, Barclays Capital, c/o
Broadridge Financial Solutions, Inc., 1155 Long Island Avenue, Edgewood, New
York 11717 (tel: 1-888-603-5847), email: barclaysprospectus(at)broadridge.com, from
Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, New
York, 10282, telephone: 1-866-471-2526, facsimile: 1-212-902-9316 or by
emailing: prospectus-ny(at)ny.email.gs.com or from SunTrust Robinson Humphrey,
Attention: Prospectus Department, 3333 Peachtree Road, NE, 11th Floor, Atlanta,
GA 30326, (tel:1-404-926-5048) or over the Internet from the Securities and
Exchange Commission's website at http://www.sec.gov.
This news release does not constitute an offer to sell or the solicitation of an
offer to buy any securities nor shall there be any sale of these securities in
any state in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such states. This
news release also does not constitute an offer to buy or the solicitation of an
offer to sell any securities.
About Omnicare
Omnicare, Inc., a Fortune 400 company based in Covington, Kentucky, provides
comprehensive pharmaceutical services to patients and providers across North
America. As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers. Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its Specialty Care Group. For more
information, visit www.omnicare.com.
Forward-looking Statements
In addition to historical information, this press release contains certain
statements that constitute "forward-looking statements." These forward-looking
statements include, but are not limited to, all statements regarding the intent,
belief or current expectations regarding the matters discussed or incorporated
by reference in this document (including, but not limited to, statements as to
"beliefs," "expectations," "anticipations," "intentions" or similar words) and
all statements which are not statements of historical fact. Such forward-
looking statements, together with other statements that are not historical, are
based on management's current expectations and involve known and unknown risks,
uncertainties, contingencies and other factors that could cause results,
performance or achievements to differ materially from those stated. These risks
and uncertainties include, but are not limited to, the possibility that Omnicare
will not pursue a transaction with PharMerica, the timing to consummate a
potential transaction between Omnicare and PharMerica, the ability and timing to
obtain required regulatory approvals, Omnicare's ability to realize the
synergies contemplated by a potential transaction, Omnicare's ability to
promptly and effectively integrate the businesses of PharMerica and Omnicare,
the performance of Omnicare's institutional pharmacy business, business
conditions in the institutional pharmacy industry generally, the inability to
expand geographically as anticipated, the inability to leverage services and
capabilities among Omnicare's network of institutional pharmacies as
anticipated, the effectiveness of Omnicare's strategy in the institutional
pharmacy business, the ability of the PharMerica acquisition to strengthen
relationships with pharmaceutical and biotechnology companies and the risks and
uncertainties described in Omnicare's Form 10-K, Form 10-Q and Form 8-K reports
filed with the Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize or should underlying assumptions prove
incorrect, Omnicare's actual results, performance or achievements could differ
materially from those expressed in, or implied by, such forward-looking
statements. Readers are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date hereof. Except as otherwise
required by law, Omnicare does not undertake any obligation to publicly release
any revisions to these forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
# # #
Contact:
Patrick C. Lee
(859) 392-3444
patrick.lee(at)omnicare.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via Thomson Reuters ONE
[HUG#1547039]
Unternehmensinformation / Kurzprofil:
Datum: 15.09.2011 - 21:00 Uhr
Sprache: Deutsch
News-ID 64562
Anzahl Zeichen: 7145
contact information:
Town:
Covington, KY
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Omnicare Announces Pricing and Increased Size of Offering of 7.75% Senior Subordinated Notes Due 2020"
steht unter der journalistisch-redaktionellen Verantwortung von
Omnicare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
